CAMP4 Begin Period Cash Flow from 2010 to 2025
| CAMP Stock | USD 4.71 0.21 4.27% |
Begin Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 76.1 M | Current Value 99.6 M | Quarterly Volatility 83.4 M |
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.26, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
CAMP4 | Begin Period Cash Flow |
Latest CAMP4 THERAPEUTICS's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of CAMP4 THERAPEUTICS PORATION over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. CAMP4 THERAPEUTICS's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CAMP4 THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
CAMP4 Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 194,152,062 | |
| Geometric Mean | 172,861,464 | |
| Coefficient Of Variation | 42.97 | |
| Mean Deviation | 77,934,922 | |
| Median | 256,500,000 | |
| Standard Deviation | 83,432,843 | |
| Sample Variance | 6961T | |
| Range | 180.4M | |
| R-Value | (0.84) | |
| Mean Square Error | 2137.5T | |
| R-Squared | 0.71 | |
| Significance | 0.000038 | |
| Slope | (14,801,723) | |
| Total Sum of Squares | 104415.6T |
CAMP4 Begin Period Cash Flow History
About CAMP4 THERAPEUTICS Financial Statements
CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 76.1 M | 99.6 M |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.